$602 Million is the total value of SECTOR GAMMA AS's 32 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 26.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABT | Sell | ABBOTT LABS | $64,928,000 | -2.0% | 1,064,562 | -3.7% | 10.79% | -9.6% |
| MRK | Buy | MERCK & CO INC | $55,469,000 | +40.4% | 913,830 | +26.0% | 9.22% | +29.5% |
| BAX | Buy | BAXTER INTL INC | $53,243,000 | +14.4% | 721,058 | +0.8% | 8.85% | +5.5% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $49,929,000 | +118.1% | 902,226 | +149.2% | 8.30% | +101.1% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $47,785,000 | +0.4% | 1,461,300 | -16.1% | 7.94% | -7.4% |
| SHPG | Buy | SHIRE PLCsponsored adr | $29,004,000 | +17.7% | 171,825 | +4.2% | 4.82% | +8.5% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $28,109,000 | -0.3% | 800,588 | -0.7% | 4.67% | -8.0% |
| PKI | Sell | PERKINELMER INC | $26,579,000 | -7.2% | 362,956 | -4.0% | 4.42% | -14.4% |
| BIO | Sell | BIO RAD LABS INCcl a | $24,944,000 | +5.8% | 86,449 | -8.3% | 4.15% | -2.4% |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $21,040,000 | -1.8% | 326,659 | -15.6% | 3.50% | -9.4% |
| ANTM | Buy | ANTHEM INC | $20,925,000 | +10.9% | 87,910 | +2.3% | 3.48% | +2.2% |
| GILD | Buy | GILEAD SCIENCES INC | $20,657,000 | +164.7% | 291,600 | +181.7% | 3.43% | +144.2% |
| NUVA | Buy | NUVASIVE INC | $19,587,000 | +0.8% | 375,807 | +1.0% | 3.26% | -7.0% |
| LLY | Sell | LILLY ELI & CO | $15,499,000 | -20.7% | 181,641 | -28.1% | 2.58% | -26.8% |
| PRGO | Buy | PERRIGO CO PLC | $14,541,000 | +26.6% | 199,440 | +44.7% | 2.42% | +16.8% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $12,636,000 | +4.8% | 303,240 | +10.9% | 2.10% | -3.4% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $10,992,000 | +6.7% | 98,633 | +13.4% | 1.83% | -1.6% |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $10,351,000 | +41.3% | 862,602 | +0.9% | 1.72% | +30.3% |
| REGN | New | REGENERON PHARMACEUTICALS | $9,832,000 | – | 28,500 | +100.0% | 1.63% | – |
| LH | Sell | LABORATORY CORP AMER HLDGS | $9,273,000 | -32.1% | 51,654 | -38.8% | 1.54% | -37.4% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $8,104,000 | -53.2% | 423,850 | -62.2% | 1.35% | -56.8% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $7,907,000 | +20.9% | 173,892 | +40.4% | 1.31% | +11.5% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $7,584,000 | +72.2% | 200,800 | +49.0% | 1.26% | +58.7% |
| PDCO | PATTERSON COMPANIES INC | $7,078,000 | +2.0% | 312,232 | 0.0% | 1.18% | -6.0% | |
| CAH | Sell | CARDINAL HEALTH INC | $6,165,000 | -56.5% | 126,263 | -44.2% | 1.02% | -59.9% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $5,228,000 | – | 68,015 | +100.0% | 0.87% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $3,201,000 | – | 32,500 | +100.0% | 0.53% | – |
| THC | Sell | TENET HEALTHCARE CORP | $3,038,000 | -76.5% | 90,503 | -83.1% | 0.50% | -78.4% |
| BLUE | New | BLUEBIRD BIO INC | $2,668,000 | – | 17,000 | +100.0% | 0.44% | – |
| ONCE | Sell | SPARK THERAPEUTICS INC | $2,615,000 | -15.7% | 31,600 | -32.2% | 0.44% | -22.2% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $2,073,000 | +13.7% | 146,000 | +52.1% | 0.34% | +4.9% |
| RGNX | New | REGENXBIO INC | $718,000 | – | 10,000 | +100.0% | 0.12% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -41,000 | -100.0% | -0.60% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -51,006 | -100.0% | -0.68% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -64,300 | -100.0% | -1.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.